Follow my blog with Bloglovin
Sunday , 21 October 2018
Breaking News

WHO VIRTUAL PRESS CONFERENCE FOLLOWING THE SECOND HIGH-LEVEL MEETING ON EBOLA VACCINES ACCESS AND FINANCING

WHAT: On 8 January 2015, WHO is convening the second high-level meeting on Ebola vaccines access and financing. The meeting is a follow-up and review of Ebola candidate vaccine clinical trials and proposed financing mechanisms.
 
The purpose of the meeting is to: provide an update on the emerging safety and immunogenicity results of Phase I clinical trials; review the candidate Ebola vaccines pipeline; review manufacturers’ plans to extend the safety database; review the status of preparation for Phase III efficacy trials in the three most-affected West African countries; and provide an update on the decision of the Gavi Board to financially support the introduction of Ebola vaccines.
 
On 9 January, after the meeting’s conclusions have been adopted, WHO Assistant Director-General Dr Marie Paule Kieny and the chair of the meeting, Professor Helen Rees, will brief journalists on developments in the area of Ebola vaccines.
 
WHEN: Virtual Press Briefing on Friday 9 January, at 12:30 CET
 
WHERE: Geneva-based journalists may participate in the Library Room at WHO Headquarters.
Journalists outside Geneva may dial in, and Dial-in numbers are listed below.
 
WHO:   Dr Marie-Paule Kieny, Assistant Director-General, WHO
                Professor Helen Rees, University of Witwatersrand (Meeting Chair)

Comments are closed.

Scroll To Top
badge